The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevir

The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevir

David R Walker, Timothy R Juday, Shivaji R Manthena, Yonghua Jing, Vipan Sood Health Economics and Outcomes Research, AbbVie Inc., North Chicago, IL, USA Background: Combination therapy with sofosbuvir (SOF) and simeprevir (SIM) is used to treat patients with hepatitis C virus infection. It is curr...

Full description

Bibliographic Details
Main Authors: Walker DR, Juday TR, Manthena SR, Jing Y, Sood V
Format: Article
Language:English
Published: Dove Medical Press 2015-12-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
adherence
hepatitis C
sofosbuvir
simeprevir
ribavirin
Online Access:https://www.dovepress.com/the-impact-of-ribavirin-on-real-world-adherence-rates-in-hepatitis-c-p-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/the-impact-of-ribavirin-on-real-world-adherence-rates-in-hepatitis-c-p-peer-reviewed-article-CEOR

Similar Items